UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Immunotherapy-Induced Acute Hepatitis in the Elderly: The Case of a Patient with Urothelial Carcinoma and a Review of the Literature

Forum of clinical oncology, 2022-02, Vol.12 (3), p.28-33

2022

Link zum Volltext

Verfügbarkeit prüfen

Advancing Colorectal Cancer Diagnosis with AI-Powered Breathomics: Navigating Challenges and Future Directions

Diagnostics (Basel), 2023-12, Vol.13 (24), p.3673

2023

Link zum Volltext

Verfügbarkeit prüfen

Melanoma and Sarcoidosis in Patients Receiving or Not Antineoplastic Therapy

Case reports in oncology, 2021-07, Vol.14 (2), p.1059-1065

2021

Link zum Volltext

Verfügbarkeit prüfen

Aromatase Inhibitor-Associated Tendinopathy and Muscle Tendon Rupture: Report of Three Cases of This Exceedingly Rare Adverse Event

Case reports in oncology, 2018-05, Vol.11 (2), p.557-561

2018

Link zum Volltext

Verfügbarkeit prüfen

Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function

International journal of cardiology, 2007-01, Vol.114 (3), p.332-338

2007

Link zum Volltext

Verfügbarkeit prüfen

Male breast cancer survival data and clinicopathological characteristics: A single-centre experience

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18837-e18837

2023

Link zum Volltext

Verfügbarkeit prüfen

Single center experience with alpelisib-fulvestrant in heavily pretreated women with HR(+), HER-2 (−) metastatic breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13034-e13034

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictive biomarkers for dasatinib treatment in melanoma

Oncoscience, 2014-03, Vol.1 (2), p.158-166

2014

Link zum Volltext

Verfügbarkeit prüfen

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

Breast cancer research and treatment, 2018-05, Vol.169 (1), p.105-113

2018

Link zum Volltext

Verfügbarkeit prüfen

Antibody–cytotoxic drug conjugates in clinical trials and future perspectives: the development of Trojan horses

Memo - Magazine of European medical oncology, 2014-02, Vol.7 (1), p.47-49

Tryfonopoulos, Dimitrios

2014

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer

Journal of cancer research and clinical oncology, 2019-05, Vol.145 (5), p.1221-1233

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-08-33: A remarkably high yield of identified hereditary breast cancer cases in a single oncology center, followed by inversely proportional rate of cascade testing in family relatives

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-08-33

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections

Clinical breast cancer, 2020-04, Vol.20 (2), p.152-159

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project

British journal of cancer, 2018-08, Vol.119 (3), p.374-380

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of cabazitaxel as second-line treatment in patients with HER-2 negative metastatic breast cancer previously treated with taxanes

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1089-1089

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

ESMO open, 2020-08, Vol.5 (4), p.e000774, Article e000774

2020

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross‑sectional study

Oncology letters, 2022-05, Vol.23 (5), p.1, Article 168

2022

Link zum Volltext

Verfügbarkeit prüfen

Salvage Chemotherapy with Cisplatin and 5-Fluorouracil in Metastatic Breast Cancer. Particular Activity against Liver Metastases

Anticancer research, 2012-05, Vol.32 (5), p.1833-1837

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of ascorbic acid on forearm reactive hyperaemia in patients with hypercholesterolaemia

European journal of cardiovascular prevention and rehabilitation, 2004-04, Vol.11 (2), p.149-154

2004

Link zum Volltext

Verfügbarkeit prüfen

Serum VEGF in patients (PTS) receiving bevacizimab (BEV) for early-stage breast cancer (ESBC): ICORG 08-10

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13520-e13520

2012

Link zum Volltext

Verfügbarkeit prüfen

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial

Therapeutic advances in medical oncology, 2019-07, Vol.11, p.1758835919864236

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic characteristics of triple-negative breast cancer and relationship to basal markers

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e11519-e11519

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(34)
Berichte
(2)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Oncology
(18)
Humans
(15)
Female
(12)
Adult
(11)
Middle Aged
(11)
Breast Cancer
(9)
Aged
(8)
Chemotherapy
(7)
Breast Neoplasms - Drug Therapy
(5)
Metastasis
(5)
Treatment Outcome
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Biological And Medical Sciences
(4)
Biomarkers
(4)
Breast Neoplasms - Pathology
(4)
Cancer
(4)
Case Report
(4)
Male
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunotherapy-Induced Acute Hepatitis in the Elderly: The Case of a Patient with Urothelial Carcinoma and a Review of the Literature

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial

Advancing Colorectal Cancer Diagnosis with AI-Powered Breathomics: Navigating Challenges and Future Directions

Melanoma and Sarcoidosis in Patients Receiving or Not Antineoplastic Therapy

Aromatase Inhibitor-Associated Tendinopathy and Muscle Tendon Rupture: Report of Three Cases of This Exceedingly Rare Adverse Event

Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function

Male breast cancer survival data and clinicopathological characteristics: A single-centre experience

Single center experience with alpelisib-fulvestrant in heavily pretreated women with HR(+), HER-2 (−) metastatic breast cancer

Predictive biomarkers for dasatinib treatment in melanoma

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

Antibody–cytotoxic drug conjugates in clinical trials and future perspectives: the development of Trojan horses

Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer

AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study

Abstract P6-08-33: A remarkably high yield of identified hereditary breast cancer cases in a single oncology center, followed by inversely proportional rate of cascade testing in family relatives

Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project

mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab

Phase II study of cabazitaxel as second-line treatment in patients with HER-2 negative metastatic breast cancer previously treated with taxanes

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross‑sectional study

Salvage Chemotherapy with Cisplatin and 5-Fluorouracil in Metastatic Breast Cancer. Particular Activity against Liver Metastases

Effect of ascorbic acid on forearm reactive hyperaemia in patients with hypercholesterolaemia

Serum VEGF in patients (PTS) receiving bevacizimab (BEV) for early-stage breast cancer (ESBC): ICORG 08-10

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial

Clinicopathologic characteristics of triple-negative breast cancer and relationship to basal markers

Suchergebnisse filtern